Advertisement

COVID-19 Federal Responses: Monday, January 24, 2022

COVID-19 Federal Responses: Monday, January 24, 2022

Congress

  • Eighteen Senators led by Sen. Debbie Stabenow (D-MI) sent a letter to the Biden Administration advocating for Medicare to cover at-home COVID-19 tests, which are not currently covered by Medicare.

White House and Federal Agencies

  • A U.S. District Court Judge issued a nationwide injunction against the Biden administration’s COVID-19 vaccine mandate for federal employees.
  • The Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky called for increasing investments in public health – mainly focused on alleviating long-term staffing issues in local hospitals and recruiting statisticians to track public health metrics.
  • The Department of Health and Human Services announced $103 million in grants to help address burnout among healthcare workers, focused on underserved and rural communities.
    • A survey found that 47% of physicians reported feeling “burnt out” over the past year, citing “an overload of bureaucratic tasks” as the main culprit.

Economy, Vaccines, Testing and Treatment

  • A study from researchers at BioNTech, Pfizer, and the University of Texas shows a booster dose of the Pfizer COVID-19 vaccine is effective against the Omicron variant for at least four months.
  • CDC data shows booster doses are 90% effective at preventing hospitalization for the Omicron variant.
  • The rollout of antiviral pills, such as Pfizer’s Paxlovid and Merck’s Molnupiravir, has been slow due to regulatory, testing, and logistical issues.
  • The National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci predicts Omicron variant infections will peak in February.
  • Pfizer’s CEO predicts people will receive annual COVID-19 vaccines.
  • As the Omicron variant spreads, nursing homes are experiencing staffing shortages.
  • A CDC study found that people vaccinated against COVID had better outcomes than unvaccinated people, and that boosted individuals were significantly better protected than un-boosted individuals.
  • According to a new study, people tend to test positive on rapid COVID-19 tests for six to 10 days after infection.

Advertisement